Cargando...
Long-acting Injectable Cabotegravir for the Prevention of HIV Infection
PURPOSE: This review highlights the development of long-acting injectable cabotegravir (CAB LA) for HIV pre-exposure prophylaxis (PrEP), with a focus on Phase 2 studies and later development. RECENT FINDINGS: Early studies of CAB LA for HIV prevention offered promising PK data and paved the way for...
Gardado en:
| Publicado en: | Curr Opin HIV AIDS |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7382946/ https://ncbi.nlm.nih.gov/pubmed/31644481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0000000000000597 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|